As part of a research programme targeting novel molecules derived from nitrogen derivatives of ohydroxyaryl ketones [1] we synthesised 7-hydroxy-8-acetylcoumarin oxime and we subsequently oxidized it with lead tetraacetate (LTA) as well as with diacetoxy iodobenzene (DIB). The reactions led to the formation of the oxidative cyclisation product, 9-methyl-2H-chromeno[8,7-d]isoxazol-2-one N-oxide , in good yields. It is well known that isoxazole ring possesses interesting biological activity especially as acetyl cholesterinase inhibitor [2] and as antimicrobial agent [3] . [4] whereas commercially available lead tetraacetate as well as diacetoxy iodobenzene were supplied by Aldrich.
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1.37 g (3.09 mmol) of LTA are added to a suspension of 0.5 g (2.30 mmol) of 7-hydroxy-8-acetylcoumarin oxime in 20 ml THF in an ice-bath. The mixture was then stirred magnetically at 0-4 ο C for 2 hrs. Filtration of the precipitate, which was formed, gave a solid which was recrystillised from petroleum ether to afford (0.33 g, 67 %) of the desired as white crystals. The product was identified by its 1 H NMR, 13 C NMR and MS and elemental analysis.
Method B
0.75 g (2.33 mmol) of DIB are added to a suspension of 0.5 g (2.30 mmol) of 7-hydroxy-8-acetylcoumarin oxime in 20 ml CH 2 Cl 2 in an ice-bath. The mixture was then stirred magnetically at r.t. for 24 hrs. Evaporation of the solvent gave an oil which was then subjected to column chromatography (silica gel 70-230 mesh). Elution with a mixture of petroleum ether / ethylacetate 1:1 afforded (0.32 g, 65 %) the desired as white crystals. The product was identified by its 1 
